Bridgefront Capital »

Edgewise Therapeutics shares owned by Bridgefront Capital

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Bridgefront Capital from 13F filings

Historical chart of Bridgefront Capital investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Bridgefront Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Bridgefront Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $372k 12k 31.50

More positions owned by Bridgefront Capital

Take-Two Interactive Software (TTWO)
TPG Com Cl A (TPG)
Constellation Brands Cl A (STZ)
Broadcom (AVGO)
Encana Corporation (OVV)
Kimberly-Clark Corporation (KMB)
Clorox Company (CLX)
Lamb Weston Hldgs (LW)
Keysight Technologies (KEYS)
EQT Corporation (EQT)
Celsius Hldgs Com New (CELH)
Amgen (AMGN)
Micron Technology (MU)
Host Hotels & Resorts (HST)
Agree Realty Corporation (ADC)

View all positions for Bridgefront Capital

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
Paradigm Biocapital Advisors
Baker Bros. Advisors
BlackRock
Henderson Group
Novo A/S
Driehaus Capital Management
Siren
Perceptive Advisors
Vanguard Capital Management
Cormorant Asset Management
Braidwell
Morgan Stanley
Geode Capital Management

View all funds holding Edgewise Therapeutics